Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1800
-0.0040 (-2.17%)
At close: May 15, 2026, 4:00 PM EDT
0.1877
+0.0077 (4.28%)
After-hours: May 15, 2026, 7:49 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $8.08 million as of May 15, 2026. Its market cap has decreased by -97.04% in one year.
Market Cap
8.08M
Enterprise Value
9.18M
1-Year Change
-97.04%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since April 28, 2025, Liminatus Pharma's market cap has decreased from $135.59M to $8.08M, a decrease of -94.04%. That is a compound annual growth rate of -93.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 6.48M | -60.67% |
| Dec 31, 2025 | 16.47M | -87.85% |
| Apr 28, 2025 | 135.59M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 9.57M |
| Genprex | 9.06M |
| CDT Equity | 8.99M |
| Curanex Pharmaceuticals | 8.94M |
| PMGC Holdings | 8.81M |
| Processa Pharmaceuticals | 8.33M |
| Creative Medical Technology Holdings | 8.28M |
| NuCana | 8.24M |